Tramadol and Tramadol Plus Ketamine for Shivering Prevention After Spinal Anesthesia in Lower Segment Caeserian Section
NCT ID: NCT06134895
Last Updated: 2023-11-18
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
PHASE4
190 participants
INTERVENTIONAL
2023-08-16
2023-11-16
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Comparison of Prophylactic Use of Tramadol Versus Ketamine for Prevention of Post Spinal Anesthesia Shivering
NCT07043049
Intravenous Tramadol and Magnesium Sulphate for Prevention of Shivering
NCT06612996
Low Dose Perioperative Ketamine Infusion and it's Effect on Postoperative Pain Score, Sedation Score and Narcotic Consumption in Patients Undergoing Spine Surgery: A Prospective Randomized Double Blind Control Trial.
NCT04259476
Comparison of Intrathecal Nalbuphine Versus Intrathecal Tramadol as Adjuvants in Subarachnoid Block for Lower Limb Orthopaedic Surgeries
NCT07294352
Nefopam vs Tramadol in the Prevention of Post Anaesthetic Shivering
NCT02441673
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Tramadol with Ketamine
Tramadol 0.25mg/Kg with Ketamine 0.25 mg/Kg
Tramadol with Ketamine
Tramadol with Ketamine is being provided randomly using prospective, double-blind
Tramadol
Tramadol 0.5mg/kg
Tramadol
Tramadol alone is being provided randomly using prospective, double-blind
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Tramadol with Ketamine
Tramadol with Ketamine is being provided randomly using prospective, double-blind
Tramadol
Tramadol alone is being provided randomly using prospective, double-blind
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* American Society of Anesthesiologist physical status I and II
* Pregnant female for lower segment caeserian section
Exclusion Criteria
* Patients with hypo- or hyperthyroidism
* Known case of Cardiopulmonary disease, pre-eclampsia and eclampsia
* An initial body temperature 38.00C or, 36.0oC assessed by thermometer
18 Years
40 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Ziauddin University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Dr Muhammad Arif
Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Muhammad Arif
Role: PRINCIPAL_INVESTIGATOR
Ziauddin University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Muhammad Arif
Karachi, Sindh, Pakistan
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
7240623MAANE
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.